Junker B, Mann Z, Gailliot P, Byrne K, Wilson J
Merck Research Laboratories, Building R810-120, Merck Research Laboratories, PO Box 2000, Rahway, New Jersey 07065, USA.
Biotechnol Bioeng. 1998 Dec 5;60(5):580-8.
A valine-overproducing mutant (MA7040, Streptomyces hygroscopicus) was found to produce 1.5 to 2.0 g/L of the immunoregulant, L-683,590, at the 0.6 m3 fermentation scale in a simple batch process using soybean oil and ammonium sulfate-based GYG5 medium. Levels of both lower (L-683,795) and higher (HH1 and HH2) undesirable homolog levels were controlled adequately. This batch process was utilized to produce broth economically at the 19 m3 fermentation scale. Material of acceptable purity was obtained without the multiple pure crystallizations previously required for an earlier culture, MA6678, requiring valine supplementation for impurity control. Investigations at the 0.6 m3 fermentation scale were conducted, varying agitation, pH, initial soybean oil/ammonium sulfate charges, and initial aeration rate to further improve growth and productivity. Mid-cycle ammonia levels and lipase activity appeared to have an important role. Using mid-cycle soybean oil additions, a titer of 2.3 g/L of L-683,590 was obtained, while titers reached 2.7 g/L using mid-cycle soybean oil and ammonium sulfate additions. Both higher and lower homolog levels remained acceptable during this fed-batch process. Optimal timing of mid-cycle oil and ammonium sulfate additions was considered a critical factor to further titer improvements.
一株过量生产缬氨酸的突变体(吸水链霉菌MA7040),在使用大豆油和基于硫酸铵的GYG5培养基的简单分批发酵过程中,在0.6立方米的发酵规模下可产生1.5至2.0克/升的免疫调节剂L - 683,590。较低(L - 683,795)和较高(HH1和HH2)的不良同系物水平均得到了充分控制。该分批发酵工艺被用于19立方米发酵规模的经济生产。获得了纯度可接受的产物,无需像早期培养物MA6678那样进行多次纯结晶,MA6678需要补充缬氨酸来控制杂质。在0.6立方米发酵规模下进行了研究,改变搅拌、pH值、初始大豆油/硫酸铵添加量和初始通气速率,以进一步提高生长和生产率。发酵中期的氨水平和脂肪酶活性似乎起着重要作用。通过在发酵中期添加大豆油,L - 683,590的效价达到了2.3克/升,而在发酵中期同时添加大豆油和硫酸铵时,效价达到了2.7克/升。在这个补料分批发酵过程中,较高和较低的同系物水平均保持在可接受范围内。发酵中期添加油和硫酸铵的最佳时机被认为是进一步提高效价的关键因素。